{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:25:08Z","timestamp":1792545908223,"version":"4.5.0"},"reference-count":73,"publisher":"Rockefeller University Press","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/Y004450\/1"],"award-info":[{"award-number":["MR\/Y004450\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["AJR00750"],"award-info":[{"award-number":["AJR00750"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bulgari"},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["227217\/Z\/23\/Z"],"award-info":[{"award-number":["227217\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Moh Family Foundation"},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:p>Seasonal booster vaccination is the primary intervention for protection from respiratory viral infections, such as influenza virus or SARS-CoV-2. However, efficacy is often limited because immune exposure to prior strains impairs development of new responses. In this study, we sought to determine how this issue could be overcome in a mouse model of heterologous immunization against WT and omicron strains of SARS-CoV-2. Intranasal booster immunization circumvented the shortcomings of intramuscular immunization, resulting in superior systemic and mucosal T and B cell immunity and better viral control following SARS-CoV-2 challenge in hamsters. Mechanistically, an intranasal omicron booster immunization bypassed deleterious immune imprinting following intramuscular ancestral strain prime, which allowed for induction of de novo lung B cell and antibody responses against the omicron strain. Cross-reactive memory T cells were also efficiently recruited into the lungs. These findings support further testing of mucosal booster vaccines against respiratory viruses, particularly as a means of simultaneously overcoming deleterious immunological imprinting and enhancing mucosal responses.<\/jats:p>","DOI":"10.1084\/jem.20241529","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T06:20:43Z","timestamp":1758781243000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms"],"prefix":"10.1084","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-663X","authenticated-orcid":true,"given":"Cameron","family":"Bissett","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0551-746X","authenticated-orcid":true,"given":"Lyn","family":"Yong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Human Genetics, University of Oxford 3 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-6961","authenticated-orcid":true,"given":"Alexandra J.","family":"Spencer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/00eae9z71","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle 4 , Callaghan,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4354-9693","authenticated-orcid":true,"given":"Fionn Nok Lam","family":"Ma","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2918-840X","authenticated-orcid":true,"given":"Ethan A.","family":"Courchesne","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}],"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Laboratory of Virology, , Hamilton, MT,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2046-2793","authenticated-orcid":true,"given":"Reshma","family":"Koolaparambil Mukesh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}],"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Laboratory of Virology, , Hamilton, MT,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4288-2892","authenticated-orcid":true,"given":"Marta","family":"Ulaszewska","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-1643","authenticated-orcid":true,"given":"Alexander","family":"Sampson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1970-322X","authenticated-orcid":true,"given":"Marie","family":"Lucienne","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6180-1903","authenticated-orcid":true,"given":"Reshma","family":"Kailath","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1813-0557","authenticated-orcid":true,"given":"Susan","family":"Morris","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3522-9486","authenticated-orcid":true,"given":"Claire","family":"Powers","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-3785","authenticated-orcid":true,"given":"Sandra","family":"Belij-Rammerstorfer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2288-3196","authenticated-orcid":true,"given":"Vincent J.","family":"Munster","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}],"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Laboratory of Virology, , Hamilton, MT,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-6359","authenticated-orcid":true,"given":"Neeltje","family":"van Doremalen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}],"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health 5 Laboratory of Virology, , Hamilton, MT,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-2216","authenticated-orcid":true,"given":"Nicholas M.","family":"Provine","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Human Genetics, University of Oxford 3 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-897X","authenticated-orcid":true,"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford Vaccine Group, University of Oxford 1 Department of Paediatrics, , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Pandemic Sciences Institute, University of Oxford 2 , Oxford,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Chinese Academy of Medical Sciences Oxford Institute, University of Oxford 6 , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2025103010371471300_bib1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","article-title":"SARS-CoV-2 Omicron boosting induces de novo B cell response in humans","volume":"617","author":"Alsoussi","year":"2023","journal-title":"Nature"},{"key":"2025103010371471300_bib2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01009-8","article-title":"Omicron: Increased transmissibility and decreased pathogenicity","volume":"7","author":"B\u00e1lint","year":"2022","journal-title":"Sig Transduct Target Ther."},{"key":"2025103010371471300_bib3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41541-024-00912-1","article-title":"Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine","volume":"9","author":"Bissett","year":"2024","journal-title":"NPJ Vaccin."},{"key":"2025103010371471300_bib4","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.eclinm.2023.102148","article-title":"Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities","volume":"63","author":"Breznik","year":"2023","journal-title":"eClinicalMedicine"},{"key":"2025103010371471300_bib5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.32760","article-title":"Estimated effectiveness of COVID-19 vaccines against omicron or delta symptomatic infection and severe outcomes","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"2025103010371471300_bib6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41385-018-0124-2","article-title":"Zymosan by-passes the requirement for pulmonary antigen encounter in lung tissue-resident memory CD8+ T cell development","volume":"12","author":"Caminschi","year":"2019","journal-title":"Mucosal Immunol."},{"key":"2025103010371471300_bib7","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.3791\/3960","article-title":"Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines","author":"Cisney","year":"2012","journal-title":"J. Vis. Exp."},{"key":"2025103010371471300_bib8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2025103010371471300_bib9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25539","article-title":"A polyvalent RNA vaccine reduces the immune imprinting phenotype in mice and induces neutralizing antibodies against omicron SARS-CoV-2","volume":"10","author":"Costa Rocha","year":"2024","journal-title":"Heliyon"},{"key":"2025103010371471300_bib10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41541-023-00645-7","article-title":"Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice","volume":"8","author":"Cotter","year":"2023","journal-title":"NPJ Vaccin."},{"key":"2025103010371471300_bib73","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.","volume":"109","author":"Cottingham","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"2025103010371471300_bib11","doi-asserted-by":"publisher","first-page":"112167","DOI":"10.1016\/j.celrep.2023.112167","article-title":"Pre-existing immunity modulates responses to mRNA boosters","volume":"42","author":"Dangi","year":"2023","journal-title":"Cell Rep."},{"key":"2025103010371471300_bib12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cell.2022.11.031","article-title":"Clonal replacement sustains long-lived germinal centers primed by respiratory viruses","volume":"186","author":"de Carvalho","year":"2023","journal-title":"Cell"},{"key":"2025103010371471300_bib13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"2025103010371471300_bib14","doi-asserted-by":"publisher","first-page":"109210","DOI":"10.1016\/j.isci.2024.109210","article-title":"SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract","volume":"27","author":"Escalera","year":"2024","journal-title":"iScience"},{"key":"2025103010371471300_bib15","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.lanepe.2023.100747","article-title":"Impact of COVID-19 on immunocompromised populations during the omicron era: Insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"2025103010371471300_bib16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/mps1010008","article-title":"Pseudotype neutralization assays: From laboratory bench to data analysis","volume":"1","author":"Ferrara","year":"2018","journal-title":"Methods Protoc."},{"key":"2025103010371471300_bib17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41577-022-00690-8","article-title":"Cross reactive T cells hold up against Omicron","volume":"22","author":"Flemming","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2025103010371471300_bib18","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","article-title":"Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates","volume":"25","author":"Gagne","year":"2024","journal-title":"Nat. Immunol."},{"key":"2025103010371471300_bib19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41541-020-00221-3","article-title":"Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19","volume":"5","author":"Graham","year":"2020","journal-title":"NPJ Vaccin."},{"key":"2025103010371471300_bib20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"2025103010371471300_bib21","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.31.478520","article-title":"Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in na\u00efve hamsters compared to ancestral vaccine","volume-title":"bioRxiv","author":"Hawman","year":"2022"},{"key":"2025103010371471300_bib22","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"2025103010371471300_bib23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41564-023-01505-9","article-title":"Immune imprinting and next-generation coronavirus vaccines","volume":"8","author":"Huang","year":"2023","journal-title":"Nat. Microbiol."},{"key":"2025103010371471300_bib24","doi-asserted-by":"publisher","first-page":"2200121","DOI":"10.2807\/1560-7917.ES.2022.27.9.2200121","article-title":"Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities \u2013 surveillance results from southern Sweden, July 2021 to January 2022","volume":"27","author":"Kahn","year":"2022","journal-title":"Euro Surveill."},{"key":"2025103010371471300_bib25","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"2025103010371471300_bib26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/pathogens12020169","article-title":"First impressions matter: Immune imprinting and antibody cross-reactivity in influenza and SARS-CoV-2","volume":"12","author":"King","year":"2023","journal-title":"Pathogens"},{"key":"2025103010371471300_bib27","doi-asserted-by":"publisher","first-page":"24224","DOI":"10.1038\/s41598-025-06880-3","article-title":"Intranasal booster induces durable mucosal immunity against SARS-CoV-2 in mice","volume":"15","author":"Koolaparambil Mukesh","year":"2025","journal-title":"Sci. Rep."},{"key":"2025103010371471300_bib28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41590-025-02156-0","article-title":"Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice","volume":"26","author":"Kwon","year":"2025","journal-title":"Nat. Immunol."},{"key":"2025103010371471300_bib29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/22221751.2022.2053365","article-title":"A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants","volume":"11","author":"Lam","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"2025103010371471300_bib30","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat. Commun."},{"key":"2025103010371471300_bib31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2025103010371471300_bib32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","article-title":"Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: A randomised, open-label, single-centre trial","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"2025103010371471300_bib33","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1080\/22221751.2022.2097479","article-title":"Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice","volume":"11","author":"Li","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"2025103010371471300_bib34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175233","article-title":"Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2","volume":"135","author":"Lin","year":"2025","journal-title":"J. Clin. Invest."},{"key":"2025103010371471300_bib35","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj8356","article-title":"Circulating KLRG1+ long-lived effector memory T cells retain the flexibility to become tissue resident","volume":"9","author":"Lucas","year":"2024","journal-title":"Sci. Immunol."},{"key":"2025103010371471300_bib36","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"2025103010371471300_bib37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","article-title":"Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques","volume":"626","author":"McMahan","year":"2024","journal-title":"Nature"},{"key":"2025103010371471300_bib38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.156372","article-title":"Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses","volume":"7","author":"McNaughton","year":"2022","journal-title":"JCI Insight"},{"key":"2025103010371471300_bib39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"2025103010371471300_bib40","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1038\/s41467-023-42433-w","article-title":"Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination","volume":"14","author":"Mitsi","year":"2023","journal-title":"Nat. Commun."},{"key":"2025103010371471300_bib41","doi-asserted-by":"publisher","first-page":"2368288","DOI":"10.1080\/21645515.2024.2368288","article-title":"Induction of protective immune responses at respiratory mucosal sites","volume":"20","author":"Park","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"2025103010371471300_bib42","doi-asserted-by":"publisher","first-page":"2167410","DOI":"10.1080\/21645515.2023.2167410","article-title":"Effectiveness of the pre-omicron COVID-19 vaccines against omicron in reducing infection, hospitalization, severity, and mortality compared to delta and other variants: A systematic review","volume":"19","author":"Paul","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"2025103010371471300_bib43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijid.2023.01.027","article-title":"Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 \u2013 February 2022)","volume":"129","author":"Petrone","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"2025103010371471300_bib44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6970","article-title":"Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection","volume":"2","author":"Pizzolla","year":"2017","journal-title":"Sci. Immunol."},{"key":"2025103010371471300_bib45","doi-asserted-by":"publisher","first-page":"104893","DOI":"10.1016\/j.ebiom.2023.104893","article-title":"SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses","volume":"98","author":"Puhach","year":"2023","journal-title":"EBioMedicine"},{"key":"2025103010371471300_bib46","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1038\/s41467-024-47451-w","article-title":"Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin","volume":"15","author":"Pu\u0161nik","year":"2024","journal-title":"Nat. Commun."},{"key":"2025103010371471300_bib47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.CLICOM.2021.10.001","article-title":"The \u201coriginal antigenic sin\u201d and its relevance for SARS-CoV-2 (COVID-19) vaccination","volume":"1","author":"Rijkers","year":"2021","journal-title":"Clin. Immunol. Commun."},{"key":"2025103010371471300_bib48","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2025103010371471300_bib49","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/v13081579","article-title":"Coronavirus Pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses","volume":"13","author":"Sampson","year":"2021","journal-title":"Viruses"},{"key":"2025103010371471300_bib50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41586-023-05715-3","article-title":"Molecular fate-mapping of serum antibody responses to repeat immunization","volume":"615","author":"Schiepers","year":"2023","journal-title":"Nature"},{"key":"2025103010371471300_bib51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.immuni.2024.05.009","article-title":"Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers","volume":"57","author":"Schiepers","year":"2024","journal-title":"Immunity"},{"key":"2025103010371471300_bib52","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4049\/jimmunol.2200297","article-title":"Prime-pull immunization of mice with a BcfA-Adjuvanted vaccine elicits sustained mucosal immunity that prevents SARS-CoV-2 infection and pathology","volume":"210","author":"Shamseldin","year":"2023","journal-title":"J. Immunol."},{"key":"2025103010371471300_bib53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"key":"2025103010371471300_bib54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3460","article-title":"Regulated selection of germinal-center cells into the memory B cell compartment","volume":"17","author":"Shinnakasu","year":"2016","journal-title":"Nat. Immunol."},{"key":"2025103010371471300_bib55","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41390-022-02163-z","article-title":"Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels","volume":"93","author":"Silva","year":"2023","journal-title":"Pediatr. Res."},{"key":"2025103010371471300_bib56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae)","volume":"8","author":"Singh","year":"2023","journal-title":"NPJ Vaccin."},{"key":"2025103010371471300_bib57","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag2031","article-title":"Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity","volume":"2","author":"Sl\u00fctter","year":"2017","journal-title":"Sci. Immunol."},{"key":"2025103010371471300_bib58","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"2025103010371471300_bib59","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.4049\/jimmunol.1002163","article-title":"Cutting edge: Hierarchy of maturity of murine memory B cell subsets","volume":"185","author":"Tomayko","year":"2010","journal-title":"J. Immunol."},{"key":"2025103010371471300_bib60","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"2025103010371471300_bib61","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"2025103010371471300_bib62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"2025103010371471300_bib63","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1860","article-title":"SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta","volume":"8","author":"van Doremalen","year":"2022","journal-title":"Sci. Adv."},{"key":"2025103010371471300_bib64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/fampra\/cmab076","article-title":"Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review","volume":"39","author":"van Kessel","year":"2022","journal-title":"Fam. Pract."},{"key":"2025103010371471300_bib65","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.xcrm.2023.101258","article-title":"Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"2025103010371471300_bib66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41392-023-01423-6","article-title":"Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"2025103010371471300_bib67","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: A data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"The Lancet"},{"key":"2025103010371471300_bib68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","article-title":"An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza","volume":"9","author":"Xing","year":"2024","journal-title":"NPJ Vaccin."},{"key":"2025103010371471300_bib69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","article-title":"Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting","volume":"625","author":"Yisimayi","year":"2024","journal-title":"Nature"},{"key":"2025103010371471300_bib70","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1038\/s41467-024-48414-x","article-title":"Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters","volume":"15","author":"Zaeck","year":"2024","journal-title":"Nat. Commun."},{"key":"2025103010371471300_bib71","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original antigenic sin: How first exposure shapes lifelong anti\u2013influenza virus immune responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J. Immunol."},{"key":"2025103010371471300_bib72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20241529\/1952489\/jem_20241529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20241529\/1952489\/jem_20241529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:37:23Z","timestamp":1761835043000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/223\/1\/e20241529\/278425\/Heterologous-mucosal-vaccine-boosting-enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20241529","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"e20241529"}}